mRNA-based vaccine candidate COReNAPCIN(R) induces robust humoral and cellular immunity in mice and non-human primates
R. Alimohammadi, M. Porgoo, M. Eftekhary, S. H. Kiaie, E. Ansari Dezfouli, M. Dehghani, K. Nasrollah, T. Malekshahab, M. Heidari, S. Pouya, M. Alimohammadi, D. Sattari Khavas, M. S. Modaresi, M. H. Ghasemi, H. Ramyar, , M. Azizi
This paper reports that the mRNA-based vaccine COReNAPCIN(R) induces strong humoral and cellular immunity and protects against SARS-CoV-2 infection in mice and non-human primates.
bioRxiv · Mar 5, 2022Immunology